SELLAS Life Sciences (SLS) Shares Outstanding (Diluted) (2012 - 2026)
Powered by 
Analysis
SELLAS Life Sciences (SLS) Shares Outstanding (Diluted) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.95 Bn | 132.10 Bn | 2.84 Bn | 255.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.78 Bn | 77.79 Bn | 3.93 Bn | 106.00 Mn |
| 3 | Argenx Se | 63.54 Bn | 58.36 Bn | 1.37 Bn | 66.03 Mn |
| 4 | Moderna | 57.67 Bn | 52.53 Bn | 52.00 Mn | 398.00 Mn |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | 210.89 Mn |
| 6 | BeOne Medicines | 40.03 Bn | 34.93 Bn | 1.53 Bn | 115.80 Mn |
| 7 | Alnylam Pharmaceuticals | 35.55 Bn | 32.24 Bn | 992.69 Mn | 138.28 Mn |
| 8 | Royalty Pharma | 28.55 Bn | 27.71 Bn | - | 556.90 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 217.35 Mn |
| 10 | SELLAS Life Sciences | 2.65 Bn | 2.65 Bn | - | 189.18 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 189.18 Mn |
| Mar 31, 2026 | 172.48 Mn |
| Dec 31, 2025 | 109.05 Mn |
| Sep 30, 2025 | 108.40 Mn |
| Jun 30, 2025 | 98.56 Mn |
| Mar 31, 2025 | 87.76 Mn |
| Dec 31, 2024 | 61.20 Mn |
| Sep 30, 2024 | 68.25 Mn |
| Jun 30, 2024 | 57.63 Mn |
| Mar 31, 2024 | 44.81 Mn |
| Dec 31, 2023 | 27.78 Mn |
| Sep 30, 2023 | 28.36 Mn |
| Jun 30, 2023 | 28.35 Mn |
| Mar 31, 2023 | 23.55 Mn |
| Dec 31, 2022 | 19.40 Mn |
| Sep 30, 2022 | 20.56 Mn |
| Jun 30, 2022 | 20.29 Mn |
| Mar 31, 2022 | 15.90 Mn |
| Dec 31, 2021 | 15.48 Mn |
| Sep 30, 2021 | 15.87 Mn |